NCT07476326
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07476326
Title Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Biocon Biologics UK PLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries TUR | ROU | ESP | BRA

Facility Status City State Zip Country Details
Biocon Investigational Site Bento Gonçalves Brazil Details
Biocon Investigational Site Ijuí Brazil Details
Biocon Investigational Site Pará Brazil Details
Biocon Investigational Site Porto Alegre Brazil Details
Biocon Investigational Site Rio de Janeiro Brazil Details
Biocon Investigational Site 1 Santa Catarina Brazil Details
Biocon Investigational Site 2 Santa Catarina Brazil Details
Biocon Investigational Site Santa Catarina Brazil Details
Biocon Investigational Site 1 São Paulo Brazil Details
Biocon Investigational Site 2 São Paulo Brazil Details
Biocon Investigational Site São Paulo Brazil Details
Biocon Investigational Site Providencia Chile Details
Biocon Investigational Site Recoleta Chile Details
Biocon Investigational Site 1 Santiago Chile Details
Biocon Investigational Site Santiago Chile Details
Biocon Investigational Site Batumi Georgia Details
Biocon Investigational Site Kutaisi Georgia Details
Biocon Investigational Site 1 Tbilisi Georgia Details
Biocon Investigational Site 2 Tbilisi Georgia Details
Biocon Investigational Site 3 Tbilisi Georgia Details
Biocon Investigational Site 4 Tbilisi Georgia Details
Biocon Investigational Site 5 Tbilisi Georgia Details
Biocon Investigational Site Tbilisi Georgia Details
Biocon Investigational Site Chisinau Moldova Details
Biocon Investigational Site Bucharest Romania Details
Site 26 Cluj-Napoca Romania Details
Biocon Investigational Site Craiova Romania Details
Biocon Investigational Site 1 Belgrade Serbia Details
Biocon Investigational Site Belgrade Serbia Details
Biocon Investigational Site Kamenitz Serbia Details
Biocon Investigational Site Kragujevac Serbia Details
Biocon Investigational Site Niš Serbia Details
Biocon Investigational Site George South Africa Details
Biocon Investigational Site 1 Johannesburg South Africa Details
Biocon Investigational Site Johannesburg South Africa Details
Biocon Investigational Site Port Elizabeth South Africa Details
Biocon Investigational Site 1 Barcelona Spain Details
Biocon Investigational Site Barcelona Spain Details
Biocon Investigational Site Madrid Spain Details
Biocon Investigational Site Murcia Spain Details
Biocon Investigational Site Sabadell Spain Details
Biocon Investigational Site 1 Seville Spain Details
Biocon Investigational Site Seville Spain Details
Biocon Investigational Site Ankara Turkey (Türkiye) Details
Biocon Investigational Site Bornova Turkey (Türkiye) Details
Biocon Investigational Site Konak Turkey (Türkiye) Details
Biocon Investigational Site Ivano-Frankivsk Ukraine Details
Biocon Investigational Site Kyiv Ukraine Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field